Clinical utility of comprehensive liquid molecular profiling in patients with advanced endometrial cancer.

MLA

Blanc, Durand, Félix, et al. “Clinical Utility of Comprehensive Liquid Molecular Profiling in Patients with Advanced Endometrial Cancer.” Cancer (0008543X), vol. 130, no. 19, Oct. 2024, pp. 3311–20. EBSCOhost, https://doi.org/10.1002/cncr.35381.

APA

Blanc, D. F., Camilleri, G. M., Bayle, A., Aldea, M., Vasseur, D., Ouali, K., Michels, J., Pautier, P., Nicotra, C., Ngo, C. M., Lacroix, L., Rouleau, E., Ponce, A. S., Italiano, A., & Leary, A. (2024). Clinical utility of comprehensive liquid molecular profiling in patients with advanced endometrial cancer. Cancer (0008543X), 130(19), 3311–3320. https://doi.org/10.1002/cncr.35381

Chicago

Blanc, Durand, Félix, Geraldine M. Camilleri, Arnaud Bayle, Mihaela Aldea, Damien Vasseur, Kaissa Ouali, Judith Michels, et al. 2024. “Clinical Utility of Comprehensive Liquid Molecular Profiling in Patients with Advanced Endometrial Cancer.” Cancer (0008543X) 130 (19): 3311–20. doi:10.1002/cncr.35381.